We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current OMIC market cap is 49.11M. The company's latest EPS is USD -37.7501 and P/E is -0.52.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 462k | 1.08M | 442k | 738k | 406k |
| Operating Income | -24.54M | -25.28M | -26.85M | -22.8M | -18.07M |
| Net Income | -22.36M | -23.25M | -25.02M | -21.25M | -16.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 765k | 2.91M |
| Operating Income | -12.77M | -27.53M | -61.28M | -93.49M | -102.8M |
| Net Income | -12.32M | -27.95M | -98.77M | -90.88M | -94.82M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 284.52M | 265.47M | 239.1M | 220M | 186.55M |
| Total Liabilities | 85.49M | 86.46M | 82.4M | 82.3M | 63.3M |
| Total Equity | 199.03M | 179.01M | 156.7M | 137.71M | 123.25M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.17M | 30.5M | 355.65M | 327.98M | 265.47M |
| Total Liabilities | 3.69M | 12.87M | 19.48M | 67.65M | 86.46M |
| Total Equity | -24.73M | -51.56M | 336.17M | 260.32M | 179.01M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -54.75M | -73.65M | -23.7M | -41.74M | -61.53M |
| Investing | 13.16M | 13.81M | 31.58M | 55.54M | 97.84M |
| Financing | 624k | 696k | N/A | 80k | 80k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.4M | -24.87M | -51.7M | -87.09M | -73.65M |
| Investing | -31.5M | 24.01M | -130.86M | -39.57M | 13.81M |
| Financing | 47.3M | 7.52M | 372.13M | 901k | 696k |
| Market Cap | 49.11M |
| Price to Earnings Ratio | -0.52 |
| Price to Sales Ratio | 17 |
| Price to Cash Ratio | 3.05 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 2.51M |
| Average Volume (1 week) | 4.96k |
| Average Volume (1 Month) | 10.03k |
| 52 Week Change | 36.90% |
| 52 Week High | 23.41 |
| 52 Week Low | 5.34 |
| Spread (Intraday) | 5.51 (22.95%) |
| Company Name | Singular Genomics Systems Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.singulargenomics.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
